Versant Voyageurs I Parallel, L.P., 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 27,850 shares at $33.13 ($682K) on 2020-11-30, disclosed to the SEC on 2020-12-01.
Scheduled sale ($682k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 6,797 | $0 | 0.0% |
| 2 | $0.00 | 467 | $0 | 0.0% |
| 3 | $33.13 | 10,193 | $338K | 49.5% |
| 4 | $33.13 | 10,193 | $338K | 49.5% |
| 5 | $34.16 | 200 | $7K | 1.0% |
| Total | $24.50 avg | 27,850 |
| $682K |
| 100% |
| Filing → |
| BDTX | SELL | 2020-10-20 | $992K | — | Filing → |
| BDTX | SELL | 2020-10-15 | $1.1M | — | Filing → |
| BDTX | SELL | 2020-10-13 | $1.4M | — | Filing → |